CVE-2019-15931: Intesync Solismed

Critical severity, CVSS 9.8. EPSS: 2.7% chance of exploitation in the next 30 days.

Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.

Affected products

• Intesync Solismed: version 3.3 only

Published 2019-12-12. Last modified 2026-06-17.